DE60330893D1 - Intrazelluläre antikörper - Google Patents
Intrazelluläre antikörperInfo
- Publication number
- DE60330893D1 DE60330893D1 DE60330893T DE60330893T DE60330893D1 DE 60330893 D1 DE60330893 D1 DE 60330893D1 DE 60330893 T DE60330893 T DE 60330893T DE 60330893 T DE60330893 T DE 60330893T DE 60330893 D1 DE60330893 D1 DE 60330893D1
- Authority
- DE
- Germany
- Prior art keywords
- intracellular
- molecule
- immunoglobulin
- target
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0226729.2A GB0226729D0 (en) | 2002-11-15 | 2002-11-15 | Intracellular antibodies |
PCT/GB2003/004942 WO2004046185A2 (en) | 2002-11-15 | 2003-11-14 | Intracellular antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60330893D1 true DE60330893D1 (de) | 2010-02-25 |
Family
ID=9947935
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60330893T Expired - Lifetime DE60330893D1 (de) | 2002-11-15 | 2003-11-14 | Intrazelluläre antikörper |
Country Status (10)
Country | Link |
---|---|
US (2) | US20050272107A1 (de) |
EP (1) | EP1560853B1 (de) |
JP (1) | JP2006518188A (de) |
AT (1) | ATE454404T1 (de) |
AU (1) | AU2003286241A1 (de) |
CA (1) | CA2506124A1 (de) |
DE (1) | DE60330893D1 (de) |
ES (1) | ES2337570T3 (de) |
GB (1) | GB0226729D0 (de) |
WO (1) | WO2004046185A2 (de) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7662554B2 (en) * | 2002-10-09 | 2010-02-16 | The Trustees Of Boston University | Nucleic acid supported protein complementation |
US20090220942A1 (en) * | 2005-10-27 | 2009-09-03 | Natalia Broude | Activated split-polypeptides and methods for their production and use |
JP2009513141A (ja) * | 2005-10-27 | 2009-04-02 | トラスティーズ オブ ボストン ユニバーシティ | タンパク質相補によるリアルタイムインビボ核酸検出 |
MX2009004464A (es) * | 2006-10-27 | 2009-11-02 | Univ Boston | Conjugados biomoleculares divididos, dirigidos para el tratamiento de enfermedades, malignidades y desordenes, y metodos para su produccion. |
GB0911215D0 (en) | 2009-06-29 | 2009-08-12 | Univ Erasmus Medical Ct | Gamma globin therapy |
TWI450415B (zh) * | 2010-03-23 | 2014-08-21 | Lg Innotek Co Ltd | 發光裝置、發光裝置封裝件及照明系統 |
GB201103631D0 (en) * | 2011-03-03 | 2011-04-13 | Univ Leeds | Identification of candidate therapeutics |
TWI640537B (zh) | 2011-12-05 | 2018-11-11 | X 染色體有限公司 | PDGF受體β結合多肽 |
US10078085B2 (en) | 2012-08-22 | 2018-09-18 | Mogam Biothechnology Institute | Screening and engineering method of super-stable immunoglobulin variable domains and their uses |
EP2920319B1 (de) | 2012-11-16 | 2020-02-19 | Poseida Therapeutics, Inc. | Ortsspezifische enzyme und verfahren zur verwendung |
LT2981822T (lt) | 2013-05-06 | 2020-12-28 | Scholar Rock, Inc. | Kompozicijos ir būdai, skirti augimo faktoriaus moduliacijai |
AU2015277180A1 (en) * | 2014-06-17 | 2017-01-12 | Poseida Therapeutics, Inc. | A method for directing proteins to specific loci in the genome and uses thereof |
US20170267784A1 (en) | 2014-10-23 | 2017-09-21 | Singh Molecular Medicine, Llc | Single domain antibodies directed against intracellular antigens |
CA2962275C (en) | 2014-10-23 | 2019-11-05 | Singh Biotechnology, Llc | Single domain antibodies directed against intracellular antigens |
US9879087B2 (en) | 2014-11-12 | 2018-01-30 | Siamab Therapeutics, Inc. | Glycan-interacting compounds and methods of use |
ES2941897T3 (es) | 2014-11-12 | 2023-05-26 | Seagen Inc | Compuestos que interaccionan con glicanos y procedimientos de uso |
EP3929286A1 (de) | 2015-06-17 | 2021-12-29 | Poseida Therapeutics, Inc. | Zusammensetzungen und verfahren zur führung von proteinen an spezifische loci im genom |
TWI746473B (zh) | 2015-11-02 | 2021-11-21 | 美商辛分子醫藥有限公司 | 針對細胞內抗原之單域抗體 |
IL258768B2 (en) | 2015-11-12 | 2023-11-01 | Siamab Therapeutics Inc | Compounds interacting with glycans and methods of use |
JP6293829B2 (ja) * | 2016-08-05 | 2018-03-14 | モガム インスティチュート フォー バイオメディカル リサーチMOGAM Institute for Biomedical Research | 安定化された免疫グロブリン可変ドメイン選別方法及び選別されたドメインの応用 |
EP3541847A4 (de) | 2016-11-17 | 2020-07-08 | Seattle Genetics, Inc. | Glycaninteragierende verbindungen und verfahren zur verwendung |
KR20240044544A (ko) | 2017-03-03 | 2024-04-04 | 씨젠 인크. | 글리칸-상호작용 화합물 및 사용 방법 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5919650A (en) * | 1990-04-22 | 1999-07-06 | Bristol-Myers Squibb Co. | Method for inactivation of protein function |
JP4436457B2 (ja) * | 1995-08-18 | 2010-03-24 | モルフォシス アイピー ゲーエムベーハー | 蛋白質/(ポリ)ペプチドライブラリー |
GB2344886B (en) * | 1999-03-10 | 2000-11-01 | Medical Res Council | Selection of intracellular immunoglobulins |
AU2003219277A1 (en) * | 2002-03-14 | 2003-09-29 | Medical Research Council | Intracellular antibodies |
US6919650B2 (en) * | 2002-05-31 | 2005-07-19 | Ballard Power Systems Corporation | Hybrid synchronization phase angle generation method |
-
2002
- 2002-11-15 GB GBGB0226729.2A patent/GB0226729D0/en not_active Ceased
-
2003
- 2003-11-14 WO PCT/GB2003/004942 patent/WO2004046185A2/en active Application Filing
- 2003-11-14 AU AU2003286241A patent/AU2003286241A1/en not_active Abandoned
- 2003-11-14 AT AT03776984T patent/ATE454404T1/de not_active IP Right Cessation
- 2003-11-14 DE DE60330893T patent/DE60330893D1/de not_active Expired - Lifetime
- 2003-11-14 CA CA002506124A patent/CA2506124A1/en not_active Abandoned
- 2003-11-14 JP JP2004552863A patent/JP2006518188A/ja active Pending
- 2003-11-14 ES ES03776984T patent/ES2337570T3/es not_active Expired - Lifetime
- 2003-11-14 EP EP03776984A patent/EP1560853B1/de not_active Expired - Lifetime
-
2005
- 2005-05-12 US US11/127,677 patent/US20050272107A1/en not_active Abandoned
-
2009
- 2009-06-22 US US12/456,845 patent/US20100143939A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004046185A2 (en) | 2004-06-03 |
CA2506124A1 (en) | 2004-06-03 |
EP1560853B1 (de) | 2010-01-06 |
US20100143939A1 (en) | 2010-06-10 |
US20050272107A1 (en) | 2005-12-08 |
ES2337570T3 (es) | 2010-04-27 |
ATE454404T1 (de) | 2010-01-15 |
WO2004046185A3 (en) | 2004-09-23 |
AU2003286241A1 (en) | 2004-06-15 |
EP1560853A2 (de) | 2005-08-10 |
GB0226729D0 (en) | 2002-12-24 |
JP2006518188A (ja) | 2006-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60330893D1 (de) | Intrazelluläre antikörper | |
Luchini et al. | Protein painting reveals solvent-excluded drug targets hidden within native protein–protein interfaces | |
MX2020000435A (es) | Anticuerpos anti-cd166 y usos de estos. | |
DK1697421T3 (da) | Bispecifikke antistoffer | |
DK1579222T3 (da) | Ikke-kompetitivt immunassay til små analytter | |
CY1113400T1 (el) | Αλλαγη των συγγενειων συνδεσης me fcrn ή των ημιζωων ορου αντισωματων με μεταλλαξιγενεση | |
EA200300362A1 (ru) | Способ генерирования молекулярно-функциональной сети | |
EA200701443A1 (ru) | Синтетические домены иммуноглобулина, обладающие свойствами связывания и сконструированные в участках молекулы, отличных от гипервариабельных участков | |
CY1109536T1 (el) | Βελτιωμενες fc πρωτεϊνες συντηξης | |
EP1864998A3 (de) | Bindungsmoleküle | |
ATE480562T1 (de) | Veränderung von fcrn-bindungsaffinitäten oder von serumhalbwertszeiten von antikörpern mittels mutagenese | |
DK0906426T3 (da) | Antistoffer mod ED-B-domænet af fibronektin, deres konstruktion og anvendelser | |
ATE517123T1 (de) | Anti-gpr-9-6 und anti-teck gerichtete antikörper und verfahren zur identifizierung von modulatoren der gpr-9-6 und teck funktion | |
DE602004001533D1 (de) | Immunotestverfahren für Herz-Troponin I | |
DE60222816D1 (de) | Identifizierung hochaffiner moleküle durch screening mit begrenzter verdünnung | |
DE69942668D1 (de) | Humanisierter monoklonaler antikörper gegen von-willebrand faktor | |
BRPI0520902A2 (pt) | Anticorpo monoclonal ou fragmento de ligação a antigeno do mesmo que se liga a proteinas psca para disgnostico de cancer, metodo para produção dos mesmos, hib'ridoma, polinucleotideo, vetor, celula, composição, ensaio para detectar a presença de uma proteina'psca e metodo de detecção de uma proteina psca | |
EE200300092A (et) | EDb-fibronektiinidomeeni retseptor | |
ATE237640T1 (de) | Monoklonaler antikörper gegen den thrombin- antithrombin komplex-iii und dessen verwendung in immunoassays | |
DE602004029589D1 (de) | Testverfahren zur bestimmung von analyten mittels analytanalogen | |
James | Spectromorphology and Spatiomorphology: Wave Terrain Synthesis as a framework for controlling Timbre Spatialisation in the frequency domain | |
DK1317564T3 (da) | Screeningsfremgangsmåder til at identificere G-proteiner og andre forbindelser, som modulerer phosphodiesterase (PDE)-aktiviteten | |
Krämer et al. | Extending the working range of immunoanalysis by exploitation of two monoclonal antibodies | |
DE60231845D1 (de) | Diagnoseverfahren für proteinprofilierung | |
Weser et al. | Detection of TAP-tagged proteins in Western blot, confocal laser scanning microscopy and FACS using the ZZ-domain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |